Results 241 to 250 of about 85,183 (283)

From anthelmintic to neuro‐oncology: A systematic review of mebendazole repurposing for brain tumour therapy

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Mebendazole (MBZ), a benzimidazole anthelmintic with established clinical use, has emerged as a repurposing candidate for primary brain tumours due to its multimodal anticancer actions and central nervous system penetrance. This systematic review synthesizes preclinical and clinical evidence evaluating MBZ's efficacy, mechanisms of action ...
Ciara B. Blum   +5 more
wiley   +1 more source

Highly cited papers in rheumatology: identification and conceptual analysis

Scientometrics, 2018
Rheumatology is a broad research area with an extensive background in scientific publications. Thus, the present study aims to identify the highly cited papers in Rheumatology research field, analyzing some aspects such as the documents distribution by years, journals, authors, institutions and countries.
M J Cobo   +2 more
exaly   +2 more sources

Development a case-based classifier for predicting highly cited papers

Journal of Informetrics, 2012
Abstract In this paper, we discussed the feasibility of early recognition of highly cited papers with citation prediction tools. Because there are some noises in papers’ citation behaviors, the soft fuzzy rough set (SFRS), which is well robust to noises, is introduced in constructing the case-based classifier (CBC) for highly cited papers.
Guang Yu   +2 more
exaly   +3 more sources

Highly cited retracted papers

Scientometrics, 2017
We examine the number of citations in 10 highly cited retracted papers, and compare their current pre- and post-citation values. We offer some possible explanations for the continued citation of these retracted papers, and point out some of the risks that may be involved for the communities that continue to cite them.
Jaime A. Teixeira da Silva   +1 more
openaire   +1 more source

Home - About - Disclaimer - Privacy